- Report
- April 2024
- 185 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 630 Pages
Global
From €9135EUR$9,500USD£7,836GBP
- Report
- January 2024
- 215 Pages
Global
From €7644EUR$7,950USD£6,558GBP
- Report
- March 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- July 2023
- 188 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- January 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- January 2024
- 145 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- October 2023
- 172 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- December 2023
- 140 Pages
Global
From €4279EUR$4,450USD£3,671GBP
- Report
- February 2024
- 72 Pages
Global
From €3841EUR$3,995USD£3,295GBP
- Report
- March 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- January 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Newsletter
- May 2024
- 88 Pages
Global
€1267EUR$1,318USD£1,087GBP
- Report
- January 2024
- 168 Pages
Global
€4803EUR$4,995USD£4,120GBP
- Report
- December 2023
- 212 Pages
Global
€4803EUR$4,995USD£4,120GBP
- Report
- December 2023
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- December 2023
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- December 2023
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- July 2023
- 223 Pages
Global
From €4327EUR$4,500USD£3,712GBP
Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more